Perioperative Cardiac Risk Management

Perioperative Cardiac Risk Management is organized by Society of Hospital Medicine (SHM).

Dates:
Release Date: Dec 17, 2018
Expiration Date: Dec 17, 2021

Accreditation:
The Society of Hospital Medicine designates this activity for a maximum of 2 AMA PRA Category 1 CreditsTM / 2.00 ABIM MOC Self Evaluation Points

Overview:
Perioperative cardiac complications are the most widely feared medical issues for the anesthesiologist, surgeon, and medical consultant as they approach a patient in the perioperative period. Only recently have management strategies been addressed in high-quality studies. The following module explains the roles of medical and interventional treatments in lowering perioperative cardiac event rates. This module also discusses the typical presentation of coronary syndromes postoperatively and the management of antiplatelet and cardiac medications.

Learning Objectives:
After completing the module, the participant should be able to:
• Analyze the evidence for beta-blocker therapy in the management of patients at elevated perioperative risk for cardiac events.
• Assess the role for statins in perioperative cardiac risk reduction.
• Discuss the importance of continuing cardiac medications in the perioperative setting and the role of clonidine, aspirin, and nitrates in reducing perioperative cardiac risk.
• Evaluate the role for coronary interventions in preoperative patients with documented ischemia on noninvasive cardiac testing.
• Discuss the perioperative management of antiplatelet therapy for patients with cardiac stents.
• Elucidate the typical presentation of postoperative myocardial infarctions and realize the utility of screening measures.